1. Assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial;ASSENT-4 PCI Investigators;Lancet,2006
2. Single bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial;Van de Werf;Lancet,1999
3. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group;Baigent;British Medical Journal,1998
4. Braunwald E Antman E Beasley J 2002 American College of Cardiology/American Heart Association Guideline for the update management of patients with unstable angina and NSTEMI: a report from the American College of Cardiology/American Heart Association Task Force on Practice Guidelines www.acc.org/qualityandscience/clinical/guidelines/unstable/update_index.htm